nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomised trial
|
von Minckwitz, G. |
|
2002 |
38 |
17 |
p. 2265-2271 7 p. |
artikel |
2 |
Calendar of Forthcoming Meetings
|
|
|
2002 |
38 |
17 |
p. I-II nvt p. |
artikel |
3 |
Cell division cycle control in embryonal and alveolar rhabdomyosarcomas
|
Moretti, A |
|
2002 |
38 |
17 |
p. 2290-2299 10 p. |
artikel |
4 |
Detection of circulating cells expressing chromogranin A gene transcripts in patients with lung neuroendocrine carcinoma
|
Bégueret, H. |
|
2002 |
38 |
17 |
p. 2325-2330 6 p. |
artikel |
5 |
Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer
|
Yamamoto, Tetsuhisa |
|
2002 |
38 |
17 |
p. 2316-2324 9 p. |
artikel |
6 |
Editorial comment on ‘A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy' by Schmitt et al.
|
Hayward, R.L |
|
2002 |
38 |
17 |
p. 2207-2209 3 p. |
artikel |
7 |
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
|
Colozza, M |
|
2002 |
38 |
17 |
p. 2279-2288 10 p. |
artikel |
8 |
European Journal of Cancer
|
|
|
2002 |
38 |
17 |
p. ii- 1 p. |
artikel |
9 |
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases
|
McKay, J.A |
|
2002 |
38 |
17 |
p. 2258-2264 7 p. |
artikel |
10 |
Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands
|
Voskuil, D.W |
|
2002 |
38 |
17 |
p. 2300-2308 9 p. |
artikel |
11 |
Mouse models to study the role of telomeres in cancer, aging and DNA repair
|
Blasco, Marı́a A |
|
2002 |
38 |
17 |
p. 2222-2228 7 p. |
artikel |
12 |
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute
|
Bacci, G. |
|
2002 |
38 |
17 |
p. 2243-2251 9 p. |
artikel |
13 |
Neoadjuvant endocrine therapy of breast cancer: a surgical perspective
|
Dixon, J.M. |
|
2002 |
38 |
17 |
p. 2214-2221 8 p. |
artikel |
14 |
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
|
von Knebel Doeberitz, M |
|
2002 |
38 |
17 |
p. 2229-2242 14 p. |
artikel |
15 |
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
|
Awada, A. |
|
2002 |
38 |
17 |
p. 2272-2278 7 p. |
artikel |
16 |
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin
|
Sharp, S.Y |
|
2002 |
38 |
17 |
p. 2309-2315 7 p. |
artikel |
17 |
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma
|
O'Hanlon, D.M |
|
2002 |
38 |
17 |
p. 2252-2257 6 p. |
artikel |
18 |
Tamoxifen 'not safe enough for chemoprevention'
|
|
|
2002 |
38 |
17 |
p. 2201-2205 5 p. |
artikel |
19 |
The future of breast cancer research in danger
|
Baum, Michael |
|
2002 |
38 |
17 |
p. 2210-2213 4 p. |
artikel |
20 |
This issue's topics
|
|
|
2002 |
38 |
17 |
p. ix-x nvt p. |
artikel |